USFDA issues warning letter to Kilitch Healthcare for Navi-Mumbai plantThe US Food and Drug Administration (USFDA) has issued a warning letter to Kilitch Healthcare India for manufacturing lapses at its plant i...
11 Apr, 2024, 03.52 PM IST
USFDA pulls up Cipla for manufacturing lapses at Pithampur plantA warning letter is issued when the US health regulator finds that a manufacturer has significantly violated its regulations. "Your firm fa...
22 Nov, 2023, 08.30 PM IST
Indian eyedrop maker issues recall of various eye drops in US for potential safety reasonsKilitch Healthcare India Limited has recalled 27 types of eye drops sold in the U.S. due to safety concerns arising from insanitary conditi...
16 Nov, 2023, 11.31 AM IST
FDA warns consumers of infection risk in over-the-counter eyedropsThe FDA warns against using over two dozen over-the-counter eyedrops due to infection risk, potentially leading to blindness. This advisory...
31 Oct, 2023, 07.03 PM IST
Pharma cos staring at some margin pressure: Surajit Pal, Prabhudas Lilladher"Non-sterile plants getting stuck for such a long time are really surprising."
18 Mar, 2019, 06.17 PM IST
Pharma cos have not worked on compliance issues: Amit Rajan, Prosfora TechConcern remains over Indian pharma’s sterile manufacturing practices, says Prosfora Tech MD
18 Mar, 2019, 02.31 PM IST
Injectable units under cloud as India lacks experts in aseptic practices: Amit Rajan, Prosfora TechIndian pharma cos putting up ANDAs and APIs in one plant to avoid paying GDUFA fee, says Rajan.
19 Feb, 2019, 03.52 PM IST
USFDA issues warning letter to Fresenius Kabi for Baddi plantThe regulator also asked Fresenius Kabi AG to ensure sufficient investigation of potential vulnerabilities in the manufacturing operation a...
03 Jan, 2018, 08.50 PM IST
Reusing single-use devices: FDA warns Fortis hospitalsFortis had received the notices and was "evaluating the observations" and would respond appropriately, its spokesperson told PTI.
27 Apr, 2017, 11.55 PM IST
USFDA issues warning letter to USV Pvt over Daman plantThe warning letter to Managing Director Prashant K Tewari raised similar current good manufacturing practice (CGMP) violations at its other...
23 Mar, 2017, 04.52 PM IST
The jewel of the Indian pharma crown has lost its shine: Amit Ranjan on Sun PharmaSun Pharma got two inspections – one for Mohali and one for Halol sight – and if you summarise, I am sorry to say that the jewel of the Ind...
14 Dec, 2016, 03.58 PM IST
USFDA issues warning letter to Wockhardt's UK facilityThe significant violations included non-adherence to appropriate written procedures that are designed to prevent contamination of drugs.
24 Nov, 2016, 01.30 AM IST
Sun Pharma needs to fix leaking roof, contamination risks at Halol: USFDAThe US FDA has directed Sun Pharma to systematically improve the oversight of manufacturing quality to ensure sustainable quality assurance.
24 Dec, 2015, 05.52 AM IST
Jubilant Life Sciences gets warning letter from USFDAJLL received a warning letter from the USFDA over violation of manufacturing norms at one of its plants located in Washington state.
05 Dec, 2013, 02.29 PM IST
USFDA warning letter to Agila not to affect acquisition: MylanMylan said the USFDA warning letter to Agila Specialties over violation of manufacturing norms in one of its plants will not affect the Rs ...
17 Sep, 2013, 06.02 PM IST
- US regulator blocks entry of 30 Ranbaxy medicines
In a severe setback for Ranbaxy, the US FDA has banned entry in the US of over 30 medicines manufactured by the drug maker at two of its In...
18 Sep, 2008, 04.29 AM IST
- US FDA warns Merck to clean up violations at plant
The Food and Drug Administration has ordered Merck & Co to correct numerous manufacturing deficiencies at its main vaccine plant, the lates...
01 May, 2008, 02.46 AM IST